Live
One Link Live rooms, co-hosting, captions, gifts and community tools.

OneLinkUS
GHOST OMNI DIVINE IS GOD LLC
OneLinkUS.com
Sign in with an existing subscription to unlock visual layouts.
Browse worldwide headlines, search any country or region, and choose a topic. Publisher photographs and video appear when available from the news source.
Explore news by country, topic and format →Headlines from publishers around the world. Search any country, region or topic.
No headlines found. Try a broader topic.
More world news →9 results for “United States The Rise of Induced Pluripotent Stem Cells - The Scientist live news”
Showing OneLink and reference results. Broader web, photo and video coverage is awaiting the search provider connection.
One Link Live rooms, co-hosting, captions, gifts and community tools.
Worldwide problem-solving, official services, emergency guidance and reliable next steps.
Advanced platform connections, AI, backend and service status.
In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory strategy for creating a viable embryo from a body cell and an egg cell. The technique consists of taking a denucleated oocyte (egg cell) and implanting a donor nucleus from a somatic (body) cell.
The stem cell controversy concerns the ethics of research involving the development and use of human embryos. Most commonly, this controversy focuses on embryonic stem cells.
Stem-cell therapy uses stem cells to treat or prevent a disease or condition. As of 2024, the only FDA-approved therapy using stem cells is hematopoietic stem cell transplantation.
An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural, and biological complexity of that organ. It is derived from one or a few stem cells from a tissue, embryonic stem cells, or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities.
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanaka and Kazutoshi Takahashi in Kyoto, Japan, who together showed in 2006 that the introduction of four specific genes (named c-Myc, Oct4, Sox2 and KLF4), collectively known as Yamanaka factors, encoding transcription factors could convert somatic
This article lists notable scientific events and developments that occurred in 2026.